Vizgen

About:

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Website: https://www.vizgen.com

Twitter/X: vizgen_inc

Top Investors: Tao Capital Partners, Sofina, Northpond Ventures, ARCH Venture Partners, Pura Vida Investments

Description:

Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution.

Total Funding Amount:

$136M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-03-07

Contact Email:

info(AT)vizgen.com

Founders:

David R. Walt, George Emanuel, Jiang He

Number of Employees:

51-100

Last Funding Date:

2024-10-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai